Synthetic absorbable hemostatic composition

Claim 2

A synthetic body absorbable hemostatic composition for use in the control of osseous hemorrhage, comprising from 60% to 80% by weight of purified polydioxanone in a biocompatible base, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15, said base comprising a natural or synthetic oil or wax which is absorbable in the body, said polydioxanone having a sufficiently low inherent viscosity such that the mixture with the base is workable and softenable by hand to bring about a putty-like consistency at room temperature and having a tackiness sufficient for it to adhere readily to a bloody bone surface and yet being able to be manipulated without crumbling or sticking to the surgeon's gloves.

Claim 3

The composition of claim 1, in which the base is selected from the group consisting of isopropyl palmitate, sesame oil, castor oil, almond oil, ethylene oxide/propylene oxide block copolymers, polyethylene glycols and methoxypolyethylene glycols.

Claim 4

The composition of claim 1 in which the polydioxanone comprises between 65% and 75% by weight of the composition.

Claim 5

The composition of claim 2 in which the inherent viscosity of the polydioxanone is about 0.1.

Claim 6

The composition of claim 3 in which the polydioxanone is present in the form of a finely pulverized powder having a particle size of less than 200 microns.

Claim 7

The composition of claim 5 in which the base is sesame oil and the polydioxanone comprises about 68% by weight of the composition.

Claim 8

A synthetic body absorbable hemostatic composition for use in the control of osseous hemorrhage, comprising from 65% to 75% by weight of purified polydioxanone in a body absorbable biocompatible base, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15, said base being selected from the group consisting of isopropyl palmitate, triglycerides, ethylene oxide/propylene oxide block copolymers, polyethylene glycols and methoxyethylene glycols, said polydioxanone having a sufficiently low inherent viscosity such that the mixture with the base is workable and softenable by hand to bring about a putty-like consistency at room temperature and having a tackiness sufficient for it to adhere readily to a bloody bone surface and yet being able to be manipulated without crumbling or sticking to the surgeon's gloves.

Claim 9

A synthetic body absorbable hemostatic composition for use in the control of osseous hemorrhage, comprising from 65% to 75% by weight of purified polydioxanone in a body absorbable biocompatible base, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15, said base being selected from the group consisting of isopropyl palmitate, triglycerides, ethylene oxide/propylene oxide block copolymers, polyethylene glycols and methoxyethylene glycols, said polydioxanone having a sufficiently low inherent viscosity such that the mixture with the base is workable and softenable by hand to bring about a putty-like consistency at room temperature and having a tackiness sufficient for it to adhere readily to a bloody bone surface and yet being able to be manipulated without crumbling or sticking to the surgeon's gloves.

Claim 10

The composition of claim 7 in which the base is a triglyceride.

Claim 11

A synthetic absorbable hemostatic composition for use in the control of osseous hemorrhage comprising by weight 65% to 75% purified polydioxanone and 25% to 35% by weight of sesame oil, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15.

Claim 12

A synthetic absorbable hemostatic composition for use in the control of osseous hemorrhage comprising by weight 65% to 75% purified polydioxanone and 25% to 35% by weight of sesame oil, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15.

Claim 13

A process for the control of bleeding from cut bone surfaces, which comprises applying to the cut bone surface a body absorbable hemostatic composition comprising from 60% to 80% by weight of purified polydioxanone in a biocompatible base, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15, said base comprising a natural or synthetic oil or wax which is absorbable in the body, said polydioxanone having a sufficiently low inherent viscosity such that the mixture with the base is workable and softenable by hand to bring about a putty-like consistency at room temperature and having a tackiness sufficient for it to adhere readily to a bloody bone surface and yet being able to be manipulated without crumbling or sticking to the surgeon's gloves.

Claim 14

A process for the control of bleeding from cut bone surfaces, which comprises applying to the cut bone surface a body absorbable hemostatic composition comprising from 60% to 80% by weight of purified polydioxanone in a biocompatible base, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15, said base comprising a natural or synthetic oil or wax which is absorbable in the body, said polydioxanone having a sufficiently low inherent viscosity such that the mixture with the base is workable and softenable by hand to bring about a putty-like consistency at room temperature and having a tackiness sufficient for it to adhere readily to a bloody bone surface and yet being able to be manipulated without crumbling or sticking to the surgeon's gloves.

Claim 15

The process of claim 10 in which the base is selected from the group consisting of isopropyl palmitate, sesame oil, castor oil, almond oil, ethylene oxide/propylene oxide block copolymers, polyethylene glycols and methoxypolyethylene glycols.

Claim 16

The process of claim 11 in which the polydioxanone comprises between 65% and 75% by weight of the composition.

Claim 17

The process of claim 12 in which the polydioxanone is present in the form of a finely divided powder having a particle size of less than 200 microns.

Claim 18

A process for the control of bleeding from cut bone surfaces, which comprises applying to the cut bone surface a hemostatic composition comprising from 65% to 75% by weight of purified polydioxanone in a body absorbable biocompatible base, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15, said base being selected from the group consisting of isopropyl palmitate, triglycerides, ethylene oxide/propylene oxide block copolymers, polyethylene glycols and methoxyethylene glycols, said polydioxanone having a sufficiently low inherent viscosity such that the mixture with the base is workable and softenable by hand to bring about a putty-like consistency at room temperature and having a tackiness sufficient for it to adhere readily to a bloody bone surface and yet being able to be manipulated without crumbling or sticking to the surgeon's gloves.

Claim 19

A process for the control of bleeding from cut bone surfaces, which comprises applying to the cut bone surface a hemostatic composition comprising from 65% to 75% by weight of purified polydioxanone in a body absorbable biocompatible base, said polydioxanone having an inherent viscosity in hexafluoroisopropanol at a concentration of 0.1 g/dl and at a temperature of 25° C. of between about 0.03 and 0.15, said base being selected from the group consisting of isopropyl palmitate, triglycerides, ethylene oxide/propylene oxide block copolymers, polyethylene glycols and methoxyethylene glycols, said polydioxanone having a sufficiently low inherent viscosity such that the mixture with the base is workable and softenable by hand to bring about a putty-like consistency at room temperature and having a tackiness sufficient for it to adhere readily to a bloody bone surface and yet being able to be manipulated without crumbling or sticking to the surgeon's gloves.